Dizal (Jiangsu) Pharmaceutical Co., Ltd.

SHSE:688192 Stock Report

Market Cap: CN¥17.7b

Dizal (Jiangsu) Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 688192?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders13,307,2723.2%
General Public37,432,5179.01%
Private Companies62,619,07115.1%
Institutions84,448,21420.3%
Public Companies108,923,02326.2%
VC/PE Firms108,923,02326.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 87.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.2%
AstraZeneca PLC
108,923,023CN¥4.7b0%no data
26.2%
SDIC Innovation Investment Management Co., Ltd.
108,923,023CN¥4.7b0%38.94%
13.8%
Jiangsu Wuxi Dizhe Enterprise Management Partnership Enterprise (Limited Partnership)
57,451,788CN¥2.5b0%no data
2.32%
Wuxi Xintou Jinshi Venture Capital Management Co., Ltd.
9,647,296CN¥411.9m0%no data
2.29%
Sequoia Capital Operations LLC
9,515,170CN¥406.3m0%0.31%
2.14%
Morgan Stanley, Investment Banking and Brokerage Investments
8,878,433CN¥379.1m0%0.01%
1.82%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
7,565,757CN¥323.1m0%13.52%
1.78%
Shanghai Liyi Investment Management Partnership (Limited Partnership)
7,413,807CN¥316.6m0%32.07%
1.76%
Zhang Xiaolin
7,310,972CN¥312.2m0%no data
1.24%
Dezent Partners Limited
5,167,283CN¥220.6m0%no data
1.09%
Zhenfan Yang
4,538,000CN¥193.8m0%no data
1.05%
Penghua Fund Management Co., Ltd.
4,365,195CN¥186.4m0%0.15%
0.81%
JPMorgan Chase & Co, Brokerage and Securities Investments
3,374,040CN¥144.1m0%0.01%
0.71%
Huashang Fund Management Company Ltd.
2,947,928CN¥125.9m0%0.24%
0.64%
China Universal Asset Management Company Ltd.
2,643,382CN¥112.9m0%0.05%
0.61%
Goldman Sachs Group, Investment Banking and Securities Investments
2,518,142CN¥107.5m0%0.01%
0.52%
Shanghai Sixie Investment Management Co., Ltd.
2,160,000CN¥92.2m0%5.3%
0.49%
China Fund Management Co., Ltd.
2,050,000CN¥87.5m0%1.14%
0.43%
Harvest Fund Management Co. Ltd.
1,774,627CN¥75.8m0%0.02%
0.39%
Bosera Asset Management Co., Ltd.
1,637,869CN¥69.9m0%0.04%
0.37%
Trinity Innovation Fund
1,558,244CN¥66.5m0%no data
0.34%
China Asset Management Co. Ltd.
1,401,811CN¥59.9m0%0.01%
0.32%
Ping An UOB Fund Management Co., Ltd.
1,340,039CN¥57.2m0%0.15%
0.27%
The Vanguard Group, Inc.
1,134,207CN¥48.4m-0.01%no data
0.27%
Yinhua Fund Management Co., Ltd.
1,110,898CN¥47.4m0%0.04%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 16:24
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dizal (Jiangsu) Pharmaceutical Co., Ltd. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Ziyu HeChina International Capital Corporation Limited
Jin ZhangChina International Capital Corporation Limited